MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-25 (medcitynews.com)
Orchestra BioMed's Hypertension Device Wins FDA Breakthrough Designation -
Orchestra BioMed's hypertension treatment is the latest medical device to earn the FDA's breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.
Read more
2025-01-20 (upphandling24.se)
Giving up on robot -
Region Västernorrland chooses settlement with a supplier of surgical robots after claiming breach of contract.
Read more
2024-09-30 (dailyguardian.ca)
Neurovascular Devices Market Global Forecasts to 2035: Medical Device Contract Manufacturers are Offering Design, Development and Production Services to Companies in the Neurovascular Device Sector
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device,
Read more
2023-12-04 (massdevice.com)
Aptar wins FDA contract to study low global warning potential metered dose inhalers
Aptar Pharma announced today that it entered into a contract with the FDA to work on low global warming potential (low-GWP) inhalers.
Read more
2023-12-01 (mddionline.com)
Insulet Signs Agreement To Provide New Drug Delivery Device for Biotech Firm Amgen Insulet Signs Agreement To Provide New Drug Delivery Device for Biotech Firm Amgen Insulet Signs Agreement To Provide New Drug Delivery Device for Biotech Firm Amgen
Insulet announces a commercial agreement by which it will deliver a new drug-delivery device to biotech firm Amgen.
Read more
2023-11-08 (healthcare-in-europe.com)
Agreement between Edwards Lifesciences and Medtronic
All patent litigation between the companies to be dismissed , All patent litigation between the companies to be dismissed
Read more
2023-11-08 (massdevice.com)
Stimvia completes enrollment in study of neurostim for Parkinson's
Stimvia announced today that it completed enrollment in a study of neuromodulation for treating Parkinson's disease and essential tremor.
Read more
2023-11-07 (massdevice.com)
Abbott launches dual-chamber pacemaker with first U.S. implants
The first U.S. commercial cases have been completed with the Abbott Aveir dual-chamber leadless pacemaker technology.
Read more
2023-05-02 (massdevice.com)
Stryker boosts guidance — but perhaps not enough — after Street-beating Q1
Stryker handily beat Wall Street expectations during its first quarter, though its guidance range increase may have disappointed investors.
Read more
2023-01-09 (medicaldevice-network.com)
Fiji Archives - Medical Device Network
Medtronic has signed an agreement for the distribution of Dragonfly Endoscopy's pancreaticobiliary system in the US. The agreement's financial terms remain …
Read more
2020-03-29 (nytimes.com)
The U.S. Tried to Build a New Fleet of Ventilators. The Mission Failed.
As the coronavirus spreads, the collapse of the project helps explain America’s acute shortage.
Read more
2019-05-01 (massdevice.com)
Robot-assisted surgery matters for contract manufacturers
Robot-assisted surgery is a game changer, not only for orthopedic device companies but the contract manufacturers serving them. For major supplier Tecomet, it means forging relationships earlier, sometimes tighter instrument tolerances — and much more.
Read more